In this context it is noteworthy that as we show in the post-mortem human tissues, LMTK2 levels are also reduced in cortex and increased in cerebellum in some transgenic mouse models of Alzheimer’s disease [29]. Here, LMTK2 is linked to early-onset autosomal dominant Alzheimer disease.